Remote Oncology Market Access Director

PharmaEssentia U.S.A.; United States; A distancia; USD 185.000 - 240.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Comprehensive medical coverage

Dental and vision coverage

Generous paid time-off

401(k) retirement plan with match

Flexible Spending Account

Descripción de la vacante

PharmaEssentia USA seeks a Key Corporate Account Director to drive access strategies across oncology networks and GPOs within the assigned territory. The role requires building stakeholder relationships, navigating formularies, and coordinating with cross-functional partners to enable product access.

Ideal candidates possess a Bachelor’s degree with 5+ years in pharma/biotech corporate accounts and are willing to travel up to 50%.

Formación

• Bachelor’s degree in a relevant field with 5+ years in pharma/biotech accounts.
• Experience engaging community oncology networks, GPOs, and health systems.
• Willingness to travel up to 50% and reside near a major airport.

Responsabilidades

• Develop and execute account-level access plans across community oncology networks, GPOs, and NCCN centers.
• Inform and execute GPO contract strategy, including pull-through activities.
• Lead engagement with population health and decision makers to secure formulary and pathway inclusion.
• Collaborate cross-functionally to deliver a coordinated customer engagement strategy.
• Maintain up-to-date account plans, CRM docs, and KPI tracking.

Conocimientos

Communication skills

Stakeholder engagement

Negotiation ability

Travel readiness

Educación

Bachelor’s degree

MBA / PharmD or related degree

Descripción del empleo

PharmaEssentia USA seeks a Key Corporate Account Director to drive access strategies across oncology networks and GPOs within the assigned territory. The role requires building stakeholder relationships, navigating formularies, and coordinating with cross-functional partners to enable product access.

Ideal candidates possess a Bachelor’s degree with 5+ years in pharma/biotech corporate accounts and are willing to travel up to 50%.